KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nasdaq (NDAQ) EBT (2016 - 2025)

Nasdaq's EBT history spans 17 years, with the latest figure at $580.0 million for Q4 2025.

  • For Q4 2025, EBT rose 32.12% year-over-year to $580.0 million; the TTM value through Dec 2025 reached $2.1 billion, up 48.14%, while the annual FY2025 figure was $2.1 billion, 48.03% up from the prior year.
  • EBT for Q4 2025 was $580.0 million at Nasdaq, up from $529.0 million in the prior quarter.
  • Across five years, EBT topped out at $580.0 million in Q4 2025 and bottomed at $278.0 million in Q4 2023.
  • The 5-year median for EBT is $386.5 million (2022), against an average of $400.2 million.
  • The largest annual shift saw EBT decreased 21.21% in 2024 before it surged 60.7% in 2025.
  • A 5-year view of EBT shows it stood at $314.0 million in 2021, then grew by 2.55% to $322.0 million in 2022, then dropped by 13.66% to $278.0 million in 2023, then surged by 57.91% to $439.0 million in 2024, then surged by 32.12% to $580.0 million in 2025.
  • Per Business Quant, the three most recent readings for NDAQ's EBT are $580.0 million (Q4 2025), $529.0 million (Q3 2025), and $548.0 million (Q2 2025).